APOE and Lewy body dementia: This study provides updated ORs for Alzheimer’s dementia for each of the six common APOE genotypes, APOE2 allelic dose, and APOE4 allelic dose on, on the differential risk of Alzheimer’s dementia, free from the confounding effects of clinically misdiagnosed cases and controls, and it demonstrates an additional impact of APOE4, but not APOE2 allelic dose on two other neuropathological disease (CAA and DLB) ORs.